Science Library Category:

ADD/ADHD

Published: 2018
SYNOPSIS

The prevalence of diagnosed ADHD in U.S. children and adolescents significantly increased over two decades, from 6.1% (1997-1998) to 10.2% (2015-2016).

TITLE

Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997-2016

Citation

Xu G, Strathearn L, Liu B, Yang B, Bao W. Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997-2016. JAMA Netw Open. 2018;1(4):e181471.

 

Summary

Among U.S. children and adolescents, the estimated prevalence of diagnosed ADHD increased significantly between 1997-1998 and 2015-2016, from 6.1% to 10.2%. The continuous increase in the prevalence of diagnosed ADHD was consistent across all subgroups.

View Abstract

TAGS
Published: 2014
SYNOPSIS

Neurodevelopmental disorders are much more common in children who received mercury-containing vaccines.

TITLE

A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopmental Disorders

CITATION

David A. Geier, Brian S. Hooker, Janet K. Kern, Paul G. King, Lisa K. Sykes, and Mark R. Geier, International Journal of Environmental Research and Public Health 2014, 11, 9156-9170; doi:10.3390/ijerph110909156

SUMMARY

On a per microgram of organic-mercury (Hg) basis, Pervasive Developmental Disorder, specific developmental disorder, tic disorder and hyperkinetic syndrome of childhood cases were significantly more likely than controls to receive increased organic-Hg exposure. This study provides new epidemiological evidence supporting a significant relationship between increasing organic-Hg exposure from vaccines and the subsequent risk of an Neurodevelopmental Disorder diagnosis.

View Abstract

TAGS
Published: 2008
SYNOPSIS

A CDC-sponsored database showed much higher rates of neurodevelopmental disabilities from mercury-containing vaccines.

TITLE

Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink

CITATION

Heather A. Young, David A. Geier, Mark R. Geier. Journal of the Neurological Sciences, 2008, 121:626-31.

SUMMARY

“Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs.”

View Abstract

TAGS
Published: 2004
SYNOPSIS

Scientists identify vaccine mercury’s role in blocking crucial neurodevelopmental pathways.

TITLE

Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal

CITATION

M Waly, H Olteanu, R Banerjee, S-W Choi, JB Mason, BS Parker, S Sukumar, S Shim,
A Sharma, JM Benzecry, V-A Power-Charnitsky and RC Deth. Molecular Psychiatry , (2004) 9, 358–370.

SUMMARY

“The ethylmercury-containing preservative thimerosal inhibited both IGF-1- and dopamine-stimulated methylation with an IC50 of 1nM and eliminated MS activity. Our findings outline a novel growth factor signaling pathway that regulates MS activity and thereby modulates methylation reactions, including DNA methylation. The potent inhibition of this pathway by ethanol, lead, mercury, aluminum and thimerosal suggest that it may be an important target of neurodevelopmental toxins.”

View Abstract

TAGS